Office of the Director, National Institutes of Health; Notice of Meeting, 28369-28370 [2021-11105]

Download as PDF Federal Register / Vol. 86, No. 100 / Wednesday, May 26, 2021 / Notices ADMINISTRATIVE, TECHNICAL, AND PHYSICAL SAFEGUARDS: These safeguards apply to the records at all locations, including at Papa Ola Lokahi (POL), an entity which collaborates with HRSA/BHW in the administration of the NHHSP through a Cooperative Agreement to assist with the implementation of the NHHSP: a. Administrative Safeguards: • Authorized Users: Passwordprotected access is limited to persons authorized and needing to use the electronic records, which includes system managers and their staff, BHW headquarter officials and staff, HRSA Division of Regional Operations staff, financial and fiscal management personnel, Office of the General Counsel personnel, Office of Information Technology personnel, and POL personnel. • Additional Authorized Users: Password-protected access is also provided to applicants, participants, and service sites for the purpose of inputting data, uploading documents, or submitting queries through BMISS. • Security controls are audited and reviewed on an ongoing basis, and security awareness training is conducted at least annually. b. Technical safeguards: • Encryption, intrusion detection, and firewalls are utilized. Scans are run against the BMISS platform for web and architecture vulnerabilities. Complex or strong passwords are required and must be changed frequently. c. Physical Safeguards: • Rooms where records are located are locked when not in use. During regular business hours, rooms are unlocked but are controlled by on-site personnel. Security guards perform random checks on the physical security of the offices (storage locations) after duty hours, including weekends and holidays. • Servers and other computer equipment used to process identifiable data are located in secured areas which use physical access control devices (e.g., keys, locks, combinations, card readers) and/or security guards to control entries into the facility. All facilities housing HRSA information systems maintain fire suppression and detection devices or systems (e.g., sprinkler systems, handheld fire extinguishers, fixed fire hoses, and or smoke detectors) that can be activated in the event of a fire. RECORD ACCESS PROCEDURES: To request access to a record about you, submit a written access request to the Policy-Coordinating Official identified in the ‘‘System Manager’’ section of this SORN, who will refer VerDate Sep<11>2014 20:00 May 25, 2021 Jkt 253001 your request to the appropriate Point of Contact for the program/activity. The request must contain your full name, address, and signature, and should also include the name of the Program(s) in which you participated (or applied but were not selected) and current status (e.g., in training, in deferment, in service, or in default), and Applicant/ Participant ID number. To verify your identity, your signature must be notarized or the request must include your written certification that you are the individual who you claim to be and that you understand that the knowing and willful request for or acquisition of a record pertaining to an individual under false pretenses is a criminal offense subject to a fine of up to $5,000. You may request that copies of the records be sent to you, or you may request an appointment to review the records in person (including with a person of your choosing, if you provide written authorization for agency personnel to discuss the records in that person’s presence). You may also request an accounting of disclosures that have been made of records about you, if any. CONTESTING RECORDS PROCEDURES: To request correction of a record about you in this system of records, submit a written amendment request to the Policy-Coordinating Official identified in the ‘‘System Manager’’ section of this SORN, who will refer your request to the appropriate Point of Contact for the program/activity. The request must contain the same information required for an access request and include verification of your identity in the same manner required for an access request. In addition, the request must reasonably identify the record and specify the information contested, the corrective action sought, and the reasons for requesting the correction; and should include supporting information to show how the record is inaccurate, incomplete, untimely, or irrelevant. NOTIFICATION PROCEDURES: To find out if the system of records contains records about you, submit a written notification request to the Policy-Coordinating Official identified in the ‘‘System Manager’’ section of this SORN who will refer your request to the appropriate Point of Contact for the program/activity. The request must contain the same information required for an access request, and must include verification of your identity in the same manner required for an access request. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 28369 EXEMPTIONS PROMULGATED FOR THE SYSTEM: None. HISTORY: 80 FR 18631 (Apr. 7, 2015), 83 FR 6591 (Feb. 14, 2018). [FR Doc. 2021–11152 Filed 5–25–21; 8:45 am] BILLING CODE 4160–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Novel and Exceptional Technology and Research Advisory Committee. The meeting will be held as a virtual meeting and is open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/). Name of Committee: Novel and Exceptional Technology and Research Advisory Committee. Date: June 25, 2021. Time: 1:00 p.m. to 3:30 p.m. Agenda: The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will discuss the Draft Report of the Gene Drives in Biomedical Research Working Group and next steps for the Committee. Place: National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892 (Virtual Meeting—Link for the meeting will be available at https://osp.od.nih.gov/ biotechnology/main-nextrac/#meetings). Contact Person: Kinshasa Letts, Office of Science Policy, National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, 301–496–9838, SciencePolicy@ od.nih.gov. To sign up to make an oral public comment, please submit your name, affiliation, and short description of the oral comment to the Contact Person listed above by 5:00 p.m. EDT, June 21, 2021. Sign up will be restricted to one sign up per email and oral comments will be limited to two minutes. Once all time slots are filled, only written comments will be accepted. Any interested person may file written comments by forwarding their statement to the Contact Person listed on this notice. The Contact Person should receive any written statements by 5:00 p.m. EDT, June 23, 2021. Information is also available on the NExTRAC web page: https://osp.od.nih.gov/ biotechnology/main-nextrac/#meetings, E:\FR\FM\26MYN1.SGM 26MYN1 28370 Federal Register / Vol. 86, No. 100 / Wednesday, May 26, 2021 / Notices where an agenda and any additional information for the meeting will be posted when available. The Draft Report of the Gene Drives in Biomedical Research Working Group will be posted prior to the meeting. Please check this website for updates. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: May 20, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–11105 Filed 5–25–21; 8:45 am] [FR Doc. 2021–11128 Filed 5–25–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Center for Scientific Review; Notice of Closed Meetings DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: NIGMS Initial Review Group; Training and Workforce Development Study Section—B Review of Predoctoral Training Grant Applications. Date: May 26, 2021. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892 (Video Meeting). Contact Person: Lisa A. Newman, SCD, Scientific Review Officer, Office of Scientific Review, National Institutes of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN18A, Bethesda, MD 20814, (301) 435–0965, newmanla2@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing 20:00 May 25, 2021 Dated: May 21, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health BILLING CODE 4140–01–P VerDate Sep<11>2014 limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Jkt 253001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Oncology 1-Basic Translational Integrated Review Group; Tumor Microenvironment Study Section. Date: June 24–25, 2021. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Angela Y. Ng, Ph.D., MBA, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6200, MSC 7804, Bethesda, MD 20892, 301–435– 1715, ngan@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: HEALthy Brain and Child Development Study Research Project Sites (U01). Date: June 25, 2021. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Contact Person: Heidi B. Friedman, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1012A, MSC 7770, Bethesda, MD 20892, 301–379– 5632, hfriedman@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Neuroscience Assays, Diagnostics, Instrumentation and Interventions. Date: June 28–29, 2021. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Joseph G. Rudolph, Ph.D., Chief and Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5186, MSC 7844, Bethesda, MD 20892, 301–408– 9098, josephru@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: High Throughput Screening. Date: June 28, 2021. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: David Filpula, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6181, MSC 7892, Bethesda, MD 20892, 301–435– 2902, filpuladr@mail.nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Neural Oxidative Metabolism and Death Study Section. Date: June 28–30, 2021. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Carol Hamelink, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4192, MSC 7850, Bethesda, MD 20892, (301) 213– 9887, hamelinc@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowship: Infectious Diseases and Immunology Panel A. Date: June 28–29, 2021. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shahrooz Vahedi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 810G, Bethesda, MD 20892, 301–496–9322, vahedis@mail.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Molecular Genetics A Study Section. E:\FR\FM\26MYN1.SGM 26MYN1

Agencies

[Federal Register Volume 86, Number 100 (Wednesday, May 26, 2021)]
[Notices]
[Pages 28369-28370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11105]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Novel and 
Exceptional Technology and Research Advisory Committee.
    The meeting will be held as a virtual meeting and is open to the 
public. Individuals who plan to view the virtual meeting and need 
special assistance or other reasonable accommodations to view the 
meeting should notify the Contact Person listed below in advance of the 
meeting. The meeting will be videocast and can be accessed from the NIH 
Videocasting and Podcasting website (https://videocast.nih.gov/).

    Name of Committee: Novel and Exceptional Technology and Research 
Advisory Committee.
    Date: June 25, 2021.
    Time: 1:00 p.m. to 3:30 p.m.
    Agenda: The Novel and Exceptional Technology and Research 
Advisory Committee (NExTRAC) will discuss the Draft Report of the 
Gene Drives in Biomedical Research Working Group and next steps for 
the Committee.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Suite 750, Bethesda, MD 20892 (Virtual Meeting--Link for the meeting 
will be available at https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings).
    Contact Person: Kinshasa Letts, Office of Science Policy, 
National Institutes of Health, 6705 Rockledge Drive, Suite 750, 
Bethesda, MD 20892, 301-496-9838, [email protected].

    To sign up to make an oral public comment, please submit your 
name, affiliation, and short description of the oral comment to the 
Contact Person listed above by 5:00 p.m. EDT, June 21, 2021. Sign up 
will be restricted to one sign up per email and oral comments will 
be limited to two minutes. Once all time slots are filled, only 
written comments will be accepted. Any interested person may file 
written comments by forwarding their statement to the Contact Person 
listed on this notice. The Contact Person should receive any written 
statements by 5:00 p.m. EDT, June 23, 2021.
    Information is also available on the NExTRAC web page: https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings,

[[Page 28370]]

where an agenda and any additional information for the meeting will 
be posted when available. The Draft Report of the Gene Drives in 
Biomedical Research Working Group will be posted prior to the 
meeting. Please check this website for updates.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: May 20, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-11105 Filed 5-25-21; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.